Filing Details
- Accession Number:
- 0001562180-22-006334
- Form Type:
- 4
- Zero Holdings:
- No
- Publication Time:
- 2022-08-26 16:14:47
- Reporting Period:
- 2022-07-29
- Accepted Time:
- 2022-08-26 16:14:47
- SEC Url:
- Form 4 Filing
Issuer
| Cik | Name | Symbol | Sector (SIC) | IRS No |
|---|---|---|---|---|
| 1395937 | Syndax Pharmaceuticals Inc | SNDX | Pharmaceutical Preparations (2834) | 320162505 |
Insiders
| Cik | Name | Reported Address | Insider Title | Director | Officer | Large Shareholder | Other |
|---|---|---|---|---|---|---|---|
| 1594274 | Peter Ordentlich | C/O Syndax Pharmaceuticals, Inc. 35 Gatehouse Drive, Building D, Floor 3 Waltham MA 02451 | Chief Scientific Officer | No | No | No | No |
Reported Non-Derivative Transactions
| Sec. Name | Acquisiton - Disposition | Date | Amount | Price | Remaning Holdings | Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|---|---|---|---|---|---|
| Common Stock | Acquisiton | 2022-07-29 | 265 | $14.12 | 265 | No | 4 | J | Direct | |
| Common Stock | Acquisiton | 2022-08-24 | 22,846 | $6.32 | 23,111 | No | 4 | M | Direct | |
| Common Stock | Disposition | 2022-08-24 | 22,846 | $25.04 | 265 | No | 4 | S | Direct | |
| Common Stock | Acquisiton | 2022-08-24 | 2,154 | $6.35 | 2,419 | No | 4 | M | Direct | |
| Common Stock | Disposition | 2022-08-24 | 2,154 | $25.04 | 265 | No | 4 | S | Direct |
| Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|
| No | 4 | J | Direct | |
| No | 4 | M | Direct | |
| No | 4 | S | Direct | |
| No | 4 | M | Direct | |
| No | 4 | S | Direct |
Reported Derivative Transactions
| Sec. Name | Sec. Type | Acquisiton - Disposition | Date | Amount | Price | Amount - 2 | Price - 2 |
|---|---|---|---|---|---|---|---|
| Common Stock | Stock Options (Right to buy) | Disposition | 2022-08-24 | 2,154 | $0.00 | 2,154 | $6.35 |
| Common Stock | Stock Options (Right to buy) | Disposition | 2022-08-24 | 22,846 | $0.00 | 22,846 | $6.32 |
| Remaning Holdings | Exercise Date | Expiration Date | Equity Swap Involved | Transaction Form Type | Transaction Code | Nature of Ownership |
|---|---|---|---|---|---|---|
| 0 | 2024-12-18 | No | 4 | M | Direct | |
| 0 | 2024-09-15 | No | 4 | M | Direct |
Footnotes
- The Reporting Person is voluntarily filing this Form 4 to report the acquisition of 265 shares by the Reporting Person on 07/29/2022 pursuant to the Issuer's Employee Stock Purchase Plan.
- The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 plan adopted by the Reporting Person. Following the sales reported in this Form 4, the Reporting Person has a total of 255,647 options to purchase shares of common stock that are vested and immediately exercisable and a total of 148,194 options to purchase shares of common stock that have not yet vested.
- The sale prices ranged from $25.00 to $25.18.
- This option is fully vested.
Billionaire Hedge Funds
